Your browser doesn't support javascript.
loading
Factors to Consider During Identification and Invitation of Individuals in a Multi-stakeholder Research Partnership.
Parker, Roses; Tomlinson, Eve; Concannon, Thomas W; Akl, Elie; Petkovic, Jennifer; Welch, Vivian A; Crowe, Sally; Palm, Marisha; Marusic, Ana; Ekanem, Comfort; Akl, Imad Bou; Saginur, Michael; Moja, Lorenzo; Kuchenmüller, Tanja; Slingers, Nevilene; Teixeira, Ligia; Dormer, Laura; Lang, Eddy; Arayssi, Thurayya; Greer-Smith, Regina; Brahem, Asma Ben; Avey, Marc; Tugwell, Peter.
Afiliación
  • Parker R; Cochrane Pain Palliative and Supportive Care Group, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Tomlinson E; Cochrane Gynaecological, Neuro-oncology and Orphan Cancers Group, Royal United Hospitals NHS Foundation Trust, Bath, UK. eve.tomlinson@bristol.ac.uk.
  • Concannon TW; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. eve.tomlinson@bristol.ac.uk.
  • Akl E; The RAND Corporation, Santa Monica, USA.
  • Petkovic J; Tufts Clinical and Translational Science Institute, Boston, USA.
  • Welch VA; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
  • Crowe S; Bruyere Research Institute, Ottawa, Ontario, Canada.
  • Palm M; Bruyere Research Institute, Ottawa, Ontario, Canada.
  • Marusic A; Crowe Associates Ltd, Thame, UK.
  • Ekanem C; Tufts Institute for Clinical Research and Health Policy Studies, Boston, USA.
  • Akl IB; Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.
  • Saginur M; Department of Clinical Governance, SERVICOM &E-Health, Ministry of Health, Calabar, Cross River State, Nigeria.
  • Moja L; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
  • Kuchenmüller T; Montfort Hospital, Montfort Research Institute, Ottawa, Canada.
  • Slingers N; Department of Health Products Policy and Standards, World Health Organization, Geneva, Switzerland.
  • Teixeira L; Research for Health Department, Science Division, World Health Organization, Geneva, Switzerland.
  • Dormer L; South African Medical Research Council, Cape Town, South Africa.
  • Lang E; Centre for Homelessness Impact, Robertson Trust, ESRC, NIHR, London, UK.
  • Arayssi T; Future Science Group, Journal of Comparative Effectiveness Research, London, UK.
  • Greer-Smith R; Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Brahem AB; Weill Cornell Medicine, Ar-Rayyan, Qatar.
  • Avey M; Healthcare Research Associates, LLC/ST.A.R. Initiative, Mountlake Terrace, USA.
  • Tugwell P; Instance Nationale de l'Evaluation et de l'Accréditation en Santé (INEAS), Tunis, Tunisia.
J Gen Intern Med ; 37(16): 4047-4053, 2022 12.
Article en En | MEDLINE | ID: mdl-35132560
ABSTRACT

BACKGROUND:

Health research teams increasingly partner with stakeholders to produce research that is relevant, accessible, and widely used. Previous work has covered stakeholder group identification.

OBJECTIVE:

We aimed to develop factors for health research teams to consider during identification and invitation of individual representatives in a multi-stakeholder research partnership, with the aim of forming equitable and informed teams.

DESIGN:

Consensus development.

PARTICIPANTS:

We involved 16 stakeholders from the international Multi-Stakeholder Engagement (MuSE) Consortium, including patients and the public, providers, payers of health services/purchasers, policy makers, programme managers, peer review editors, and principal investigators.

APPROACH:

We engaged stakeholders in factor development and as co-authors of this manuscript. Using a modified Delphi approach, we gathered stakeholder views concerning a preliminary list of 18 factors. Over two feedback rounds, using qualitative and quantitative analysis, we concentrated these into ten factors. KEY

RESULTS:

We present seven highly desirable factors 'expertise or experience', 'ability and willingness to represent the stakeholder group', 'inclusivity (equity, diversity and intersectionality)', 'communication skills', 'commitment and time capacity', 'financial and non-financial relationships and activities, and conflict of interest', 'training support and funding needs'. Additionally, three factors are desirable 'influence', 'research relevant values', 'previous stakeholder engagement'.

CONCLUSIONS:

We present factors for research teams to consider during identification and invitation of individual representatives in a multi-stakeholder research partnership. Policy makers and guideline developers may benefit from considering the factors in stakeholder identification and invitation. Research funders may consider stipulating consideration of the factors in funding applications. We outline how these factors can be implemented and exemplify how their use has the potential to improve the quality and relevancy of health research.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 11_ODS3_cobertura_universal / 2_ODS3 Problema de salud: 11_governance_arrangements / 2_cobertura_universal Asunto principal: Participación de los Interesados Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: J Gen Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 11_ODS3_cobertura_universal / 2_ODS3 Problema de salud: 11_governance_arrangements / 2_cobertura_universal Asunto principal: Participación de los Interesados Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: J Gen Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
...